Laboratory reagents (Норвегия - Тендер #41477643) | ||
| ||
| Для перевода текста тендера на нужный язык воспользуйтесь приложением: | ||
Страна: Норвегия (другие тендеры и закупки Норвегия) Организатор тендера: SYKEHUSINNKJØP HF Номер конкурса: 41477643 Дата публикации: 05-05-2023 Источник тендера: Единая система закупок Европейского союза TED |
||
Norway-Vadsø: Laboratory reagents
2023/S 088-269277
Voluntary ex ante transparency notice
Supplies
Section I: Contracting authority/entity
Section II: Object
Voluntary ex-ante transparency notice: Infection immunological analyses for microbiology at Oslo University Hospital
Oslo University Hospital intends to enter into a contract with Diasorin AB to extend contract 20160831701 infection immunological analyses. Contract 20160831701was signed with Diasorin AB in 2017 for analyses carried out at the Microbiology Department.
The extension, which is to be seen as an award of a new contract, will be entered into in accordance with a procurement without a contest, in accordance with the public procurement regulations, § 13-4 letter b).
Oslo University Hospital aims to sign the contract shortly after the deadline listed in the Public Procurement Regulations § 25-3 ten days after publication of this announcement has expired.
The analyses that are included in contract 20170831701 are: Adenovirus, Borrelia, Cytomegalovirus, Epstein-Barr virus, Helicobacter Pyroli, Herpes simplex virus, Morbillivirus, Parotittvirus, Parvovirus B19, Rotavirus, Treponema Screen, Varicella Zoster-virus, and QuantiFeron-TB Gold Plus.
All the analyses are fully automatic on the analysis instrument Liaison XL, and the contract also covers the right to use such equipment at the Unit for Serology Ullevål and the Unit for Virology and Infection Immunology, Rikshospitalet respectively. The instruments have two-way communication with the respective unit"s laboratory data system. Fully automatic analyses and two-way communication with the laboratory data system are minimum requirements for all the analyses.
Option for an extension for one year at a time until the Microbiology Department has moved to the Life Science Building.
Section IV: Procedure
The QuantiFeron TB-IGRA method will be used for screening for tuberculosis, tracing infection in outbreaks of tuberculosis, and detecting latent tuberculosis in persons with weakened immune systems. Fully automatic analysis of this is only possible on Liaison XL; Diasorin has a monopoly on the delivery of reagents for Liaison XL.
In 2027 the Microbiology Department at Oslo University Hospital will be co-located in the new Life Science Building, and will then use the analysis hall system that is procured for the Life Science Building.
The most efficient use of society"s resources will be to keep the current system until the department move to the Life Science Building, also if QuantiFeron TB-IGRA is available on another analysis instrument before the department moves to the Life Science Building.
Section V: Award of contract/concession
Infection immunological analyses (other analyses).
Section VI: Complementary information